Tuesday, January 08, 2019 5:27:15 PM
Research Partnerships
LiveWire is in the process of entering into partnerships with an experienced team of innovators, developers and institutions with the goal to develop and commercialize cannabinoid-based products for distribution and licensing to LiveWire clients, as soon as this is legally feasible.
The Company will soon begin with research studies to explore the application of cannabinoid-based products to target specific ailments or
conditions with a large “sufferer” population Growing Sophistication - Tissue Culture Cultivation
The industry and its customers have grown more sophisticated during the last two years. Companies have been struggling to provide top quality products that are based on credible research and can pass tests by a credible verification systems. Based on this experience, LiveWire
will explore and develop new advances in cloning techniques such as tissue culture cultivation. Since tissue cultures are not considered
cannabis plants, it will allow LiveWire to ship tissue cultures across state lines. This will create another competitive advantage for the Company and enable its customers to produce high-quality and organically clean cannabis on a consistent basis.
$LVVV FTW!!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM